HuGE Literature Finder
Records 1-30
|
Variation in VKORC1 is Associated with Vascular Dementia.
Journal of Alzheimer's disease : JAD 2021 Feb . Mur Jure, McCartney Daniel L, Chasman Daniel I, Visscher Peter M, Muniz-Terrera Graciela, Cox Simon R, Russ Tom C, Marioni Riccardo |
|
Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio.
Pharmacogenetics and genomics 2019 Oct 29 (8): 200-206. Kim Woorim, Yee Jeong, Chang Byung Chul, Chung Jee Eun, Lee Kyung Eun, Gwak Hye S |
|
Genetic variant in the promoter region of microRNA-137 reduces the warfarin maintenance dose in patients with atrial fibrillation.
Molecular medicine reports 2019 Apr . Tian Zhen, Yang Yushuang, Feng Zhaohui, Wu Donghui, Yang Wei, Liu Dong |
|
Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
BMC cardiovascular disorders 2018 May 18 (1): 96. Li Jiao, Yang Wenlong, Xie Zhonghui, Yu Kun, Chen Yuhua, Cui Kaij |
|
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
European journal of clinical investigation 2018 Mar e12929. Serna María José, Rivera-Caravaca José Miguel, Gonzalez-Conejero Rocío, Esteve-Pastor María Asunción, Valdés Mariano, Vicente Vicente, Lip Gregory Y H, Roldán Vanessa, Marín Francis |
|
The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.
The pharmacogenomics journal 2017 Dec . Colàs-Campàs L, Royo J L, Montserrat M V, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy |
|
Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
|
Predictors of warfarin dose requirements in South African patients attending an anticoagulation clinic.
Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2017 Mar 35 (1): 27-30. Schapkaitz Elise, Sithole Johan |
|
DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation.
Australasian physical & engineering sciences in medicine 2017 Jan . Huang Tao-Sheng, Zhang Ling, He Qiong, Li Yu-Bin, Dai Zhong-Li, Zheng Jian-Rui, Cheng Pei-Qi, He Yun-Sh |
|
Impact of GGCX polymorphisms on warfarin dose requirements in atrial fibrillation patients
Turkish journal of medical sciences 2017 08 47 (4): 1239-1246. Jiang Nian-Xin, Xu Ying-Hui, Xia Jing-Wen, Jiang Bing, Li Yan-So |
|
Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
International journal of clinical pharmacology and therapeutics 2017 02 55 (2): 126-132. Chen Weirong, Wu Luhua, Liu Xin, Shen Yue, Liang Yan, Zhu Jun, Tan Huiqiong, Yang Yanmin, Liu Qun, Wang Mingsheng, Liu Lisheng, Wang Xing |
|
Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2016 Jun 67 (3): 385-93. Wypasek E, Mazur P, Bochenek M, Awsiuk M, Grudzien G, Plincer D, Undas |
|
Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients.
Biomedical reports 2016 Apr 4 (4): 453-458. Jiang Nian-Xin, Ge Jun-Wei, Xian Yu-Qiong, Huang Shao-Ying, Li Yan-So |
|
[Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population].
Zhonghua yi xue za zhi 2016 Mar 96 (10): 776-80. Li C B, Dai D P, Hu G X, Pu C W, Cao Y P, Cai J |
|
Comparison of aspirin and Naoxintong Capsule () with adjusted-dose warfarin in elderly patients with high-risk of non-valvular atrial fibrillation and genetic variants of vitamin K epoxide reductase.
Chinese journal of integrative medicine 2016 Feb . Wang Huan, Zhou Xiao-Kai, Zheng Li-Fan, Wu Xiao-Ying, Chen H |
|
High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol.
Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
|
VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts).
The International journal of risk & safety in medicine 2015 Nov 27 Suppl 1 S17-8. Chertovskikh Y V, Malova E U, Maksimova N R, Popova N V, Sychev D |
|
Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.
Journal of stroke 2015 May 17 (2): 192-8. Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Kim Suk Jae, Kim June Soo, Lee Soo-Youn, Bang Oh You |
|
[Association of VKORC1 gene -1639G/A polymorphism with atrial fibrillation in ethnic Uygurs and Hans from Xinjiang].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015 Apr 32 (2): 264-8. Wu Peisong, Meng Siqi, Zhou Xianhui, Xu Guojun, Li Jinxin, Zhang Yu, Sun Ling, Xing Qiang, Sun Shuai, Wang Hongli, Zhou Qina, Tang Baope |
|
[HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy].
Kardiologiia 2015 55 (9): 50-6. Moreva O V, Kropacheva E S, Panchenko E P, Dobrovolsky A B, Zemlyanskaya O A, Donnikov A E, Titaeva E V, Guskova I |
|
Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.
Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
|
Pharmacogenetics role in the safety of acenocoumarol therapy.
Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
|
[Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2014 Jun 31 (3): 367-71. Lou Ying, Han Lulu, Li Yan, Zhang Xiaoxing, Liu Zhihong, Tang Min, Yu Haiwen, Wang Wei, Xu Jianping, Liu Hong, Li Yis |
|
A randomized trial of genotype-guided dosing of warfarin.
The New England journal of medicine 2013 Dec 369 (24): 2294-303. Pirmohamed Munir, Burnside Girvan, Eriksson Niclas, Jorgensen Andrea L, Toh Cheng Hock, Nicholson Toby, Kesteven Patrick, Christersson Christina, Wahlström Bengt, Stafberg Christina, Zhang J Eunice, Leathart Julian B, Kohnke Hugo, Maitland-van der Zee Anke H, Williamson Paula R, Daly Ann K, Avery Peter, Kamali Farhad, Wadelius Mia, |
|
An acenocoumarol dose algorithm based on a South-Eastern European population.
European journal of clinical pharmacology 2013 Nov 69 (11): 1901-7. Pop Tudor Radu, Vesa ?tefan Cristian, Trifa Adrian Pavel, Cri?an Sorin, Buzoianu Anca Da |
|
Impact of genetic and clinical factors on dose requirements and quality of anticoagulation therapy in Polish patients receiving acenocoumarol: dosing calculation algorithm.
Pharmacogenetics and genomics 2013 Nov 23 (11): 611-8. Wolkanin-Bartnik Jolanta, Pogorzelska Hanna, Szperl Ma?gorzata, Bartnik Aleksandra, Koziarek Jacek, Bilinska Zofia |
|
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model.
Clinical pharmacokinetics 2013 May 52 (5): 359-71. Abduljalil Khaled, Lazar Simone, Natanzon Michael, Wu Weidong, Zadoyan Gregor, Steffens Benedict, Kohl Victoria, Mörike Klaus, Tomalik-Scharte Dorota, Stingl Julia, Schwab Matthias, Harenberg Job, Gleiter Christoph, Fuhr U |
|
Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.
Thrombosis journal 2013 11 (1): 14. Nshimyumukiza Léon, Duplantie Julie, Gagnon Mathieu, Douville Xavier, Fournier Diane, Lindsay Carmen, Parent Marc, Milot Alain, Giguère Yves, Gagné Christian, Rousseau François, Reinharz Dani |
|
CYP2C9 and VKORC1 Gene Polymorphism is Inessential for Bleeding Development under Conditions of Oral Application of Anticoagulant Acenocoumarol in Russian Patients at High Risk of Thromboembolic Complications.
Bulletin of experimental biology and medicine 2012 Oct 153 (6): 6. Sychev DV, Ignatyev IV, Emelyanov NV, Milovanova VV, Kossovskaya AV, Kukes IV, Tashenova AI, Kukes VG |
|
Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 05, 2021
- Content source: